Homing exosomes following natural Blueprint for targeted drug delivery
BMEMat · 18.11.2026
DOI: 10.1002/bmm2.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMEMat, online erschienen am 18.11.2026. Verfasst von Mingliang Zhu und 4 weiteren Autor:innen. Die Arbeit nennt 325 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Substantial efforts have been devoted to improve the delivery of nanodrugs and their therapeutic efficacy through prolonged circulation, enhanced target accumulation, and intelligent transport. Among these drug delivery platforms, exosomes have emerged as particularly promising natural nanocarriers. As a key subtype of extracellular vesicles, exosomes are secreted by virtually all cell types under physiological and pathological conditions and play an essential role in intercellular communication. Characterized by low immunogenicity, excellent biocompatibility, and inherent stability, exosomes possess unique homing properties, enabling them to actively navigate toward their parental cells or pathological environments, guided by surface adhesion molecules, integrins, and tetraspanins inherited from the cell membranes. This intrinsic targeting capability offers a compelling paradigm for precision drug delivery. To further understand the intrinsic capacity of homing exosomes and better design exosome‐based nanodrugs, the sources, structure, engineering, and diverse applications of exosome delivery systems in tumors, neurological and cardiovascular diseases, orthopedic disorders, and renal diseases are summarized. In addition, the promising clinical translation and current limitations of these natural carriers are discussed with a view to provide perspectives on future research directions and inspire potential solutions. In this review, we systematically summarized the biological characterization of exosomes, with emphasis on their discovery, biogenesis, structural features, and homing mechanisms that underpin their utility as nanocarriers. We then provided a comprehensive overview of the application of homing exosomes across a broad spectrum of diseases, including tumors, neurological disorders, cardiovascular diseases, bone pathologies, autoimmune conditions, renal diseases, tissue regeneration, and chronic respiratory diseases. For each disease context, we highlighted the representative strategies involving the loading of chemotherapeutic agents, antibodies, nucleic acids, and other therapeutic cargos. Furthermore, we discussed the current landscape of clinical translation, including the development of readily available products to facilitate the clinical adoption of homing exosomes as next‐generation targeted nanocarriers. Finally, we offered perspectives on the development of exosomes, addressing the key challenges related to surface engineering, scalable manufacturing, standardization, and regulatory considerations.
Zitieren
APA
Zhu, M., Yue, L., You, Q., Jia, Y., & Chen, X. (2026). Homing exosomes following natural Blueprint for targeted drug delivery. BMEMat. https://doi.org/10.1002/bmm2.70156
Vancouver
Zhu M, Yue L, You Q, Jia Y, Chen X. Homing exosomes following natural Blueprint for targeted drug delivery. BMEMat. 2026. doi:10.1002/bmm2.70156
BibTeX
@article{Zhu2026,
author = {Zhu, Mingliang and Yue, Ludan and You, Qing and Jia, Yinnong and Chen, Xiaoyuan},
title = {Homing exosomes following natural Blueprint for targeted drug delivery},
journal = {BMEMat},
year = {2026},
doi = {10.1002/bmm2.70156}
}
EUVIMED